These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9921398)

  • 1. [Immunosuppressive agents in Horton's disease. Which drug for which indication?].
    Roblot P
    Ann Med Interne (Paris); 1998 Nov; 149(7):441-7. PubMed ID: 9921398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
    Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
    Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving therapeutic options for patients with giant cell arteritis.
    Pipitone N; Salvarani C
    Curr Opin Rheumatol; 2008 Jan; 20(1):17-22. PubMed ID: 18281852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of complicated Horton's disease].
    Généreau T
    Rev Prat; 1999 Mar; 49(6):618-22. PubMed ID: 10218399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are steroids alone sufficient for the treatment of giant cell arteritis?
    Pipitone N; Boiardi L; Salvarani C
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):277-92. PubMed ID: 15857796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressor treatment in temporal arteritis of long-term evolution].
    Roig López de los Mozos A; Calvo Catalá J; Hortelano Martínez E; Liñana Santafé JJ; González-Cruz Cervellera MI; Ballester Belda JE
    An Med Interna; 1992 Apr; 9(4):181-2. PubMed ID: 1581454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
    Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid sparing therapeutic approaches to polymyalgia rheumatica-giant cell arteritis. State of the art and perspectives.
    Ferraccioli GF; Di Poi E; Damato R
    Clin Exp Rheumatol; 2000; 18(4 Suppl 20):S58-60. PubMed ID: 10948766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Role of dapsone in the treatment of Horton's disease and polymyalgia rheumatica].
    Doury P; Fabresse FX; Pattin S; Eulry F; Celton H; Larroque P
    Ann Med Interne (Paris); 1984; 135(1):31-5. PubMed ID: 6703568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Polymyalgia rheumatica and giant-cell temporal arteritis].
    Tereshchenko IV
    Klin Med (Mosk); 2006; 84(8):25-30. PubMed ID: 17087187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Corticosteroid saving-up in giant cell arteritis?].
    Schnabel A
    Dtsch Med Wochenschr; 2002 Sep; 127(37):1910. PubMed ID: 12226792
    [No Abstract]   [Full Text] [Related]  

  • 12. Methotrexate treatment in pediatric Crohn disease patients intolerant or resistant to purine analogues.
    Weiss B; Lerner A; Shapiro R; Broide E; Levine A; Fradkin A; Bujanover Y
    J Pediatr Gastroenterol Nutr; 2009 May; 48(5):526-30. PubMed ID: 19412004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant cell (temporal) arteritis: an overview and update.
    Rahman W; Rahman FZ
    Surv Ophthalmol; 2005; 50(5):415-28. PubMed ID: 16139037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
    Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
    Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate treatment in large vessel vasculitis and polymyalgia rheumatica.
    Spies CM; Burmester GR; Buttgereit F
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S172-7. PubMed ID: 21044455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do steroids increase lymphoma risk? A case-control study of lymphoma risk in polymyalgia rheumatica/giant cell arteritis.
    Askling J; Klareskog L; Hjalgrim H; Baecklund E; Björkholm M; Ekbom A
    Ann Rheum Dis; 2005 Dec; 64(12):1765-8. PubMed ID: 15843445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Follow-up studies in polymyalgia rheumatica and temporal arteritis].
    Li J; Tang FL; Wang XD; Yu JH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Dec; 24(6):643-5. PubMed ID: 12905697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polymyalgia rheumatica and giant cell arteritis: recent data and current situation].
    Announ N; Guerne PA
    Rev Med Suisse; 2008 Mar; 4(149):696-8, 701. PubMed ID: 18472729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of steroid with azathioprine in treatment of giant cell autoimmune hepatitis.
    Eroğlu Y; Düzovali O; Kavukçu S; Irken G; Büyükgebiz B
    Turk J Pediatr; 1997; 39(4):565-71. PubMed ID: 9433162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular manifestations of Horton disease: an underestimated disease in cardiology].
    Le Tourneau T; Agraou B; Beregi JP; Maurage CA; Asseman EP
    Arch Mal Coeur Vaiss; 1997 Oct; 90(10):1403-7. PubMed ID: 9539841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.